This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bergen Teknologioverføring as. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Knut Teigen: Innovator in Pharmacological Treatments
Introduction
Knut Teigen is a notable inventor based in Bergen, Norway. He has made significant contributions to the field of pharmacology, particularly in the treatment of metabolic disorders. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Knut Teigen holds a patent for his invention titled "Hyperphenylalaninemia and treatments thereof." This patent relates to compounds of formula (I) that serve as pharmacological chaperones. These compounds have a stabilizing effect on phenylalanine hydroxylase (PAH) for the treatment of hyperphenylalaninemia (HPA), especially phenylketonuria (PKU). The compounds include trimethoprim and its analogues and derivatives.
Career Highlights
Throughout his career, Knut Teigen has worked with various organizations that focus on technological advancements and innovation. He has been associated with Bergen Teknologioverføring AS and Vestlandets Innovasjonsselskap AS, where he contributed to the development of new technologies and solutions.
Collaborations
Knut has collaborated with several professionals in his field, including Aurora Martinez and Oscar Aubi Catevilla. These collaborations have enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Knut Teigen's work in pharmacological treatments showcases his dedication to improving health outcomes through innovative solutions. His contributions to the field are significant and continue to influence advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile